Dámaso Molero

Chief Executive Officer at

3P Biopharmaceuticals SL

Health Technology

Consumer Services

Miscellaneous

Profile

Currently, Dámaso Molero is the Chief Executive Officer at 3P Biopharmaceuticals SL since 2006.
Formerly, the roles included Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche Holding AG.
Education includes undergraduate and MBA degrees from the University of Navarra.

Dámaso Molero active positions

Companies	Position	Start
3P Biopharmaceuticals SL 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules	Chief Executive Officer	01/04/2007

All active positions of Dámaso Molero

Former positions of Dámaso Molero

Companies	Position	End
SHIONOGI & CO., LTD.	Corporate Officer/Principal	-
ROCHE HOLDING AG	Corporate Officer/Principal	-
Syntex, Inc. Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment	Corporate Officer/Principal	-
Glaxo, Inc.	Corporate Officer/Principal	-

See the detail of Dámaso Molero's experience

Training of Dámaso Molero

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dámaso Molero's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Roche Holding AG Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics	Health Technology
Shionogi & Co., Ltd. Shionogi & Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of pharmaceuticals & diagnostic reagents	Health Technology
University of Navarra University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
3P Biopharmaceuticals SL 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules	Health Technology
Syntex, Inc. Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment	Miscellaneous
Glaxo, Inc.